Publicacións en colaboración con investigadores/as de University Hospital of Lausanne (30)

2024

  1. Penumbral Rescue by normobaric O = O administration in patients with ischemic stroke and target mismatch proFile (PROOF): Study protocol of a phase IIb trial

    International Journal of Stroke, Vol. 19, Núm. 1, pp. 120-126

  2. Romidepsin Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Versus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Previously Untreated Peripheral T-Cell Lymphoma: Final Analysis of the Ro-CHOP Trial

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 42, Núm. 14, pp. 1612-1618

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

2022

  1. A first update on mapping the human genetic architecture of COVID-19

    Nature

  2. Hyperoxemia in postsurgical sepsis/septic shock patients is associated with reduced mortality

    Critical Care, Vol. 26, Núm. 1

  3. Peri-operative red blood cell transfusion in neonates and infants: NEonate and Children audiT of Anaesthesia pRactice IN Europe: A prospective European multicentre observational study

    European Journal of Anaesthesiology, Vol. 39, Núm. 3, pp. 252-2560

  4. Recovery of dialysis patients with COVID-19: health outcomes 3 months after diagnosis in ERACODA

    Nephrology Dialysis Transplantation, Vol. 37, Núm. 6, pp. 1140-1151

  5. Romidepsin Plus CHOP Versus CHOP in Patients With Previously Untreated Peripheral T-Cell Lymphoma: Results of the Ro-CHOP Phase III Study (Conducted by LYSA)

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 40, Núm. 3, pp. 242-251

  6. Sex differences in COVID-19 mortality risk in patients on kidney function replacement therapy

    Scientific Reports, Vol. 12, Núm. 1

2021

  1. A population-based registry analysis on hospitalized covid-19 patients with previous cardiovascular disease: Clinical profile, treatment, and predictors of death

    Journal of Cardiovascular Development and Disease, Vol. 8, Núm. 12

  2. Binding Potassium to Improve Treatment With Renin-Angiotensin-Aldosterone System Inhibitors: Results From Multiple One-Stage Pairwise and Network Meta-Analyses of Clinical Trials

    Frontiers in Medicine, Vol. 8

  3. Clinical Profile, Pharmacological Treatment, and Predictors of Death Among Hospitalized COVID-19 Patients With Acute Kidney Injury: A Population-Based Registry Analysis

    Frontiers in Medicine, Vol. 8

  4. Current clinical practice in disabling and chronic migraine in the primary care setting: results from the European My-LIFE anamnesis survey

    BMC Neurology, Vol. 21, Núm. 1

  5. Difficult tracheal intubation in neonates and infants. NEonate and Children audiT of Anaesthesia pRactice IN Europe (NECTARINE): a prospective European multicentre observational study

    British Journal of Anaesthesia, Vol. 126, Núm. 6, pp. 1173-1181

  6. Healthcare data for achieving a more personalized treatment of chronic kidney disease

    Biomedicines

  7. Mapping the human genetic architecture of COVID-19

    Nature, Vol. 600, Núm. 7889, pp. 472-477

  8. Need of guidance in disabling and chronic migraine identification in the primary care setting, results from the european MyLife anamnesis survey

    BMC Family Practice, Vol. 22, Núm. 1

  9. Neurology training and research in the COVID-19 pandemic: a survey of the Resident and Research Fellow Section of the European Academy of Neurology

    European Journal of Neurology, Vol. 28, Núm. 10, pp. 3437-3442

2020

  1. A systematic review of neurological manifestations of SARS-CoV-2 infection: the devil is hidden in the details

    European Journal of Neurology, Vol. 27, Núm. 9, pp. 1712-1726

  2. The inhibition of complement system in formal and emerging indications: Results from parallel one-stage pairwise and network meta-analyses of clinical trials and real-life data studies

    Biomedicines, Vol. 8, Núm. 9